Diabetes, Digestive, and Kidney Diseases Extramural Research in Massachusetts
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $932 million to recipients in Massachusetts in 719 grants from fiscal 2021 to 2025, 9.7% of the program's national total. The General Hospital Corporation received the most, $186 million.
- Awarded in Massachusetts$932 million
- Awards719
- Share of the program9.7%
- Rank among states2nd of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 395 | $178 million |
| FY 2022 | 395 | $183 million |
| FY 2023 | 396 | $184 million |
| FY 2024 | 400 | $197 million |
| FY 2025 | 354 | $191 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Nonprofits | 152 | $186 million |
| The Children's Hospital Corporation | Nonprofits | 94 | $125 million |
| Brigham & Womens Hospital Inc | Nonprofits | 75 | $110 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 78 | $104 million |
| Joslin Diabetes Center, Inc. | Nonprofits | 45 | $91.6 million |
| University of Massachusetts Medical School | Colleges and universities | 46 | $62.6 million |
| The Broad Institute, Inc | Nonprofits | 13 | $37.7 million |
| Dana-Farber Cancer Institute, Inc. | Nonprofits | 28 | $30.1 million |
| President and Fellows of Harvard College | Colleges and universities | 20 | $26.8 million |
| Trustees of Boston University | Colleges and universities | 23 | $19.4 million |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Massachusetts?
$932 million from fiscal 2021 to 2025, across 719 awards. Massachusetts ranks 2nd of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Massachusetts?
The largest recipient is The General Hospital Corporation, with $186 million in 152 awards. Next are The Children's Hospital Corporation and Brigham & Womens Hospital Inc.
Can organizations in Massachusetts apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research